title: Low JC virus antibody index during natalizumab treatment less safe than assumed?
authors.affiliation: Department of Neurology and Radiology (MS Center Amsterdam), VU University Medical Center, The Netherlands j.killestein@vumc.nl.
authors.forename: Joep
authors.initials: J
authors.lastname: Killestein
authors.affiliation: Department of Neurology and Radiology (MS Center Amsterdam), VU University Medical Center, The Netherlands.
authors.forename: Mike P
authors.initials: MP
authors.lastname: Wattjes
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D006801:Humans; D007577:JC Virus / Q000276:immunology*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000821:virology; D009103:Multiple Sclerosis / Q000188:drug therapy; D000069442:Natalizumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab